Neurotoxicity Syndromes: all 139 studies
Page 2 of 2. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.
- Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal CancerStatus unknownNCT01372787
- Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Nerve DamageTerminatedNCT01293851
- A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of OxaliplatinWithdrawnNCT01157039Phase 2
- Oral Glutamine in the Prevention of Oxaliplatin-induced NeurotoxicityCompletedNCT01087658Phase 3
- Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade GliomaActive, not recruitingNCT00978458Phase 3
- Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving OxaliplatinStatus unknownNCT00884767Phase 2
- Acute Pain Caused by Paclitaxel in Patients With CancerCompletedNCT00860041
- Switching From One Type of Anti-rejection Drug (Tacrolimus or Cyclosporine) to Another (Sirolimus) Approximately 90-180 Days After Liver TransplantationWithdrawnNCT00834496
- Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerCompletedNCT00814086Phase 1
- Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast CancerCompletedNCT00755313
- Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSLWithdrawnNCT00734773Early Phase 1
- Protective Effect of Mangafodipir Against Oxaliplatin NeurotoxicityCompletedNCT00727922Phase 2
- Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System LymphomaCompletedNCT00727831Phase 1/2
- Neurotoxicity in Primary Central Nervous System Lymphoma (PCNSL): An International Observational Study of Cognition in Long Term SurvivorsTerminatedNCT00710151
- Combination Chemotherapy in Treating Younger Patients With Hodgkin LymphomaCompletedNCT00666484Phase 2
- Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This QuestionnaireCompletedNCT00517621Phase 2
- Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain MetastasesTerminatedNCT00469937Phase 1
- Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic LeukemiaCompletedNCT00437060
- Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Treated on Clinical Trial CCLG-GC-1979-01 or CCLG-GC-1989-01Status unknownNCT00436774
- Scopolamine Treatment for Patients With Organophosphate PoisoningWithdrawnNCT00389259Not applicable
- Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid TumorsCompletedNCT00305799
- Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.CompletedNCT00305188Phase 3
- Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for CancerCompletedNCT00281853
- Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerStatus unknownNCT00274885Phase 4
- XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV ChemotherapyCompletedNCT00272051Phase 3
- Nerve Function in Older Diabetic Patients Who Are Undergoing Chemotherapy for Metastatic Solid TumorsCompletedNCT00263861Not applicable
- A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate NeurotoxicityTerminatedNCT00176553Not applicable
- Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for CancerCompletedNCT00112996Phase 3
- Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic LeukemiaCompletedNCT00085176
- Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid TumorsCompletedNCT00078845Phase 2
- Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and DepressionTerminatedNCT00069927Phase 2
- Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for CancerCompletedNCT00058071Phase 3
- Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly PaclitaxelCompletedNCT00039780Phase 3
- Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201CompletedNCT00028509
- Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing ChemotherapyCompletedNCT00027963Phase 3
- Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal MethotrexateCompletedNCT00018967Not applicable
- Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial CancerTerminatedNCT00003624Phase 2
- Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and PaclitaxelCompletedNCT00003569
- Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung CancerCompletedNCT00003072Phase 2